U.S. to impose 100% tariff on branded, patented drugs unless firms build plants locally, Trump says

U.S. to impose 100% tariff on branded, patented drugs unless firms build plants locally, Trump says


Shelf of pharmaceutical products.

D3sign | Moment | Getty Images

President Donald Trump announced Thursday that the U.S. will impose a 100% tariff on “any branded or patented Pharmaceutical Product” entering the country from Oct. 1.

The measure will not apply to companies building drug manufacturing plants in the U.S., Trump added.

He said that the exemption covers projects where construction has started, including sites that have broken ground or are under construction.

“There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started,” Trump added in a post on Truth Social.

The announcement came as Trump also unveiled a 25% duty on heavy trucks and a 50% levy on “all Kitchen Cabinets, Bathroom Vanities, and associated products,” which will also start on Oct. 1.

In August, Trump told CNBC’s “Squawk Box” that planned tariffs on pharmaceuticals imported into the U.S. could eventually reach up to 250%, the highest rate he has threatened so far.

He said he will initially impose a “small tariff” on pharmaceuticals, but then in a year to a year and a half “maximum,” he will raise that rate to 150% and then 250%.

The new duties follow the launch of fresh  announced on Wednesday into imports of robotics, industrial machinery, and medical devices.

The latest probes by the Department of Commerce expand the list of goods that could face higher tariffs to include personal protective equipment such as surgical masks, N95 respirators, gloves and other medical consumables, including syringes and needles.

“Pharmaceuticals, such as prescription drugs, over-the-counter drugs, biologics, and specialty drugs, will not be covered under this investigation as those imports are being examined in a separate Section 232 investigation,” the Commerce Department said.

Any new duties resulting from the sector-specific probes would be stacked on top of Trump’s country-specific tariffs, though the European Union and Japan have reached agreements that could shield them from extra levies.

This is breaking news, please check back for updates.



Source

BYD bids Warren Buffett’s Berkshire an unfazed farewell: Selling is ‘normal’
World

BYD bids Warren Buffett’s Berkshire an unfazed farewell: Selling is ‘normal’

(This is the Warren Buffett Watch newsletter, news and analysis on all things Warren Buffett and Berkshire Hathaway. You can sign up here to receive it every Friday evening in your inbox.) Hours after we first reported last week that Berkshire sold off the remainder of its stake in BYD earlier this year, the Chinese electric vehicle maker confirmed […]

Read More
The resilient stock market may be keeping the economy out of a recession. Why that’s a bad thing
World

The resilient stock market may be keeping the economy out of a recession. Why that’s a bad thing

Traders work on the floor at the New York Stock Exchange in New York City, U.S., Sept. 17, 2025. Brendan McDermid | Reuters Stock market growth that seems impervious to tariffs, politics and a moribund jobs picture is in turn powering consumer spending and putting a floor under an economy that many expected to be […]

Read More
These stocks including an industrial giant are close to forming a dreaded ‘death cross’ chart pattern
World

These stocks including an industrial giant are close to forming a dreaded ‘death cross’ chart pattern

Several publicly traded companies’ stocks are on the verge of forming a technical pattern that signals trouble ahead. A “death cross” is a pattern that appears on a chart as a stock’s short-term moving average, typically measured over 50 days, breaks below its long-term moving average, usually taken over 200 days. The technical indicator is […]

Read More